Progenitor Cell Therapy Adds Development and Manufacturing Expertise
Marta Schilling Joins Progenitor Cell Therapy as Director of its West Coast Manufacturing Operations
Categories
DomaniCell Now Collecting and Banking Immune System and Stem Cells for the Entire Family
Your Wellness Plan Now May Include Storing Your Own Stem Cells and Immune System Cells for Future Use
AMORCYTE CARDIAC CELL THERAPY TRIAL COMPLETES SECOND OF FOUR PHASES
Stem cell therapy trial picks up pace with three sites now accruing patients
Progenitor Cell Therapy LLC and Invitrogen Corp. Enter Into Strategic Comarketing & Development Agreement
Common cell therapy focus brings industry leaders into collaboration
AMORCYTE CARDIAC CELL THERAPY TRIAL PASSES FIRST STAGE AND OPENS TWO NEW SITES
Stem cell therapy trial proceeds to next stage and opens in two new clinical centers
Progenitor Cell Therapy Expands Contract Process Development Capacity
Product development capacity doubled at Progenitor Cell Therapy
Amorcyte Secures Additional Funding to Expand Clinical Program in Cardiovascular Cell Therapy
PA Early Stage joins Colt Ventures in expanding Amorcyte’s product program
DomaniCell Obtains Stem Cell Banking License
DomaniCell Cord Blood Banking Program Obtains New Jersey State License
Two Industry Leaders Join Progenitor Cell Therapy Board
Manufacturing and market experts added to Progenitor Cell Therapy’s Board of Managers
Progenitor Cell Therapy Hosts UK Trade Mission
UK Department of Trade and Industry visits Progenitor Cell Therapy in tour of leading U.S. cell and tissue therapy companies